Home › Markets › Health Care › GUTS

Fractyl Health Inc. (GUTS)

GUTS trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$4.03
-8.73% on the day
Market cap
$53.4M
Micro cap
Revenue · 2025
$0
No prior year to compare
Net income · 2025
-$141.0M

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1572616/000119312526121793/0001193125-26-121793-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.

Profile

FieldValue
TickerGUTS on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2024
SEC CIK0001572616
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$0
Net income-$141.0M
Operating income-$96.8M
Net marginNeeds revenue and net income
Operating marginOperating income not reported
Revenue growthNo prior-year revenue to compare
Cash$81.5M
Total assets$121.4M
P/E (computed)Net income was not positive
P/S (computed)Needs market cap and revenue

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-09-26
Latest annual report10-K2026-03-24
Latest quarterly / interim10-Q2026-08-10
Latest current report8-K2026-10-01
Latest proxyDEF 14A2026-08-24

Source: SEC EDGAR submissions feed, 225 recent filings. All filings on EDGAR.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
DRIODarioHealth Corp.$5.54+2.21%$54.3M
MDAISpectral AI Inc.$1.56-2.50%$50.2M
SNWVSANUWAVE Health Inc.$5.61-3.94%$48.3M
TELATELA Bio Inc.$1.06-1.39%$48.1M
SRTSSensus Healthcare Inc.$2.89-1.36%$47.6M
DXRDaxor Corporation$10.35+0.45%$60.4M
XTNTXtant Medical Holdings Inc.$0.3243-1.43%$45.5M
MBOTMicrobot Medical Inc.$1.02-1.92%$68.5M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier